Decisions by the U.S. Food and Drug Administration (FDA) have a tremendous impact on Israeli-based medical and pharmaceutical companies that manufacture products that are marketed and sold in the United States and around the world. On Jan. 20, 2015, the FDA issued two anticipated draft guidance documents proposing reduced FDA oversight of two types of…